Some types of insulin are available over the counter in the United States, but not all. Older formulations known as “human insulin,” specifically Regular insulin and NPH insulin, can be purchased at most pharmacies without a prescription. Newer, faster-acting or long-acting insulin analogs still require one.
Which Insulins You Can Buy Without a Prescription
The two types of insulin sold over the counter are Regular insulin (sold as Novolin R and Humulin R) and NPH insulin (sold as Novolin N and Humulin N). A premixed version combining the two, called 70/30, is also available without a prescription. These are all “human insulin” formulations that have been around for decades.
Walmart sells these under its ReliOn brand, which has historically been one of the most affordable options. A 10mL vial of ReliOn insulin has typically cost well under $100. The exact price varies by location and product, but this is significantly cheaper than most prescription insulin analogs at full retail price.
What you cannot buy over the counter are the rapid-acting analogs (like NovoLog, Humalog, or Apidra) or the long-acting analogs (like Lantus, Basaglar, or Tresiba). These all require a prescription. Walmart does carry a prescription-only ReliOn NovoLog, which costs around $73 for a vial or $86 for a box of five pens, but you’ll need a doctor’s order to get it.
How OTC Insulin Works Differently
The reason this distinction matters is that over-the-counter insulin behaves differently in your body than the prescription analogs most people with diabetes use today. Understanding the timing differences is important if you’re considering a switch.
Regular insulin starts working within 30 to 60 minutes after injection, peaks at 2 to 4 hours, and lasts 5 to 8 hours. That means you need to inject it well before a meal, not right as you sit down to eat. Rapid-acting analogs, by comparison, kick in within about 15 minutes, which makes mealtime dosing much more flexible and predictable.
NPH insulin takes 1 to 2 hours to start working, has a broad peak between 4 and 12 hours, and lasts 14 to 24 hours. That wide peak window is the key issue. Long-acting prescription analogs like Lantus deliver a much flatter, more consistent level of insulin over 24 hours, which reduces the risk of unexpected blood sugar drops. NPH’s pronounced peak means your blood sugar can dip significantly hours after injection, especially if you skip a meal or change your activity level.
Risks of Switching to OTC Insulin
Buying insulin over the counter can be a lifeline if you’ve lost insurance coverage or can’t afford your prescription. But switching from a modern analog to human insulin without guidance carries real risks. A World Health Organization review of the evidence found that switching from a long-acting analog to NPH insulin could roughly double the rate of severe low blood sugar episodes. Blood sugar control also tends to worsen slightly, with average glucose levels creeping up after the switch.
The timing differences are the main culprit. If you’ve been taking a long-acting analog once a day and switch to NPH, you may need to split your dose into two daily injections, reduce the total amount by about 20%, and pay closer attention to when you eat relative to your injections. Getting the morning dose wrong, for example, can cause a dangerous blood sugar drop before lunch.
None of this means OTC insulin doesn’t work. It kept people with diabetes alive for years before analogs existed. But it requires more planning around meals, more frequent blood sugar monitoring, and a solid understanding of its timing profile. If you’re making this switch out of financial necessity, a pharmacist or diabetes educator can help you adjust your dosing safely.
The $35 Insulin Cap and How It Applies
If you’re on Medicare, the Inflation Reduction Act capped insulin copays at $35 per month for any insulin product covered under Medicare Part D or Part B. This applies to both prescription analogs and human insulin. Several major insulin manufacturers have also voluntarily capped out-of-pocket costs at $35 for many patients with private insurance.
These caps have narrowed the price gap between OTC human insulin and prescription analogs considerably. If you have any form of insurance, it’s worth checking whether your prescription insulin now falls under a $35 cap before switching to an OTC version. For uninsured individuals, OTC insulin at retail price may still be the most affordable option, but manufacturer patient assistance programs are another avenue worth exploring.
Buying Syringes Without a Prescription
If you’re buying vials of OTC insulin, you’ll also need syringes. Syringe access laws vary by state. Many states, like North Carolina, allow pharmacies to sell syringes to anyone without a prescription, without ID, and without quantity limits. Other states have stricter rules that may require a prescription for syringes or limit how many you can purchase at once.
In practice, most pharmacies that sell OTC insulin will also sell you the appropriate syringes. If you run into difficulty, ask the pharmacist directly. Insulin pen versions of OTC insulin are also available at some retailers, which sidestep the syringe question entirely since the needle is built into the pen system. Pen needles are generally easier to buy without restrictions.
Who OTC Insulin Is Meant For
Over-the-counter insulin exists as a safety net. It’s most commonly purchased by people with Type 2 diabetes who have lost access to their usual prescription, whether due to insurance gaps, travel, or an emergency situation where they can’t reach their doctor. For someone rationing insulin or going without because of cost, walking into a pharmacy and buying a vial of Novolin without a prescription can be genuinely lifesaving.
For people with Type 1 diabetes, OTC insulin is a much riskier substitute. Type 1 requires precise basal and bolus dosing, and the unpredictable peaks of NPH and the slower onset of Regular insulin make tight control significantly harder. It can work in an emergency, but it’s not a long-term replacement for a modern insulin regimen without close medical supervision.